139 related articles for article (PubMed ID: 10232930)
1. Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
Dalton JT; Meyer MC; Golub AL
Drug Metab Dispos; 1999 Apr; 27(4):432-5. PubMed ID: 10232930
[TBL] [Abstract][Full Text] [Related]
2. Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.
Klem B; Lappin G; Nicholson S; van de Wetering J; de Vries DE; Oosterhuis B; Garner RC
J Clin Pharmacol; 2006 Apr; 46(4):456-60. PubMed ID: 16554454
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits.
Ritschel WA; Grummich KW; Hussain SA
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):41-8. PubMed ID: 3157841
[TBL] [Abstract][Full Text] [Related]
5. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
6. Dose and species dependent pharmacokinetics of a novel sigma receptor antagonist, DuP 734.
Kapil RP; Lam GN
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):3-20. PubMed ID: 7620836
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
8. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
Kuroha M; Shirai Y; Shimoda M
J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
[TBL] [Abstract][Full Text] [Related]
9. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
10. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.
Dalton JT; Yates CR; Yin D; Straughn A; Marcus SL; Golub AL; Meyer MC
J Pharmacol Exp Ther; 2002 May; 301(2):507-12. PubMed ID: 11961050
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.
Dalton JT; Zhou D; Mukherjee A; Young D; Tolley EA; Golub AL; Meyer MC
Pharm Res; 1999 Feb; 16(2):288-95. PubMed ID: 10100316
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
[TBL] [Abstract][Full Text] [Related]
14. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
[TBL] [Abstract][Full Text] [Related]
16. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs.
Ritschel WA; Neub M; Denson DD
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):811-5. PubMed ID: 3441166
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of pidotimod in rats and dogs.
Coppi G; Silingardi S
Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2.
Rees WA; Harkins JD; Lu M; Holland RE; Lehner AF; Tobin T; Chambers TM
Am J Vet Res; 1999 Jul; 60(7):888-94. PubMed ID: 10407485
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.
Bekersky I; Puhl RJ; Hanson G; Mong S
Drug Metab Dispos; 1994; 22(2):233-6. PubMed ID: 8013279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
